Related Experiment Videos
Summary
Sudden infant death may result from sepsis in infants with asplenia syndrome, a condition causing impaired immunity. Early detection of asplenia using Howell-Jolly bodies and prompt antibiotic treatment can improve outcomes.
Area of Science:
- Pediatric Medicine
- Genetics
- Immunology
Background:
- Ivemark syndrome is a rare condition associated with congenital malformations.
- Asplenia, the absence of a spleen, can lead to impaired immune function and increased susceptibility to infection.
- Congenital cardiovascular malformations and visceral heterotaxy are sometimes linked to Ivemark syndrome.
Observation:
- Two families presented with a history of asplenia, gastrointestinal malformations, cardiovascular malformations, or Ivemark syndrome.
- Infants with asplenia experienced high mortality rates, with sepsis being a contributing factor in deaths.
- Ivemark syndrome may encompass isolated asplenia and congenital heart disease without asplenia.
Findings:
- Sudden infant death can be attributed to sepsis in cases of isolated asplenia syndrome.
- Early identification of asplenia is crucial for preventing life-threatening infections.
- Howell-Jolly bodies in peripheral blood smears are an indicator for asplenia screening.
Implications:
- Infants born into families with a history of related conditions should be screened for asplenia.
- Prophylactic antibiotics are recommended for infants diagnosed with asplenia.
- Pneumococcal polysaccharide vaccine at age 2 and screening programs for Howell-Jolly bodies are advised for at-risk infants.